Mads Detlef Sorensen

Title: Mads Detlef Sorensen: Innovator in Locked Nucleic Acid Derivatives

Introduction

Mads Detlef Sorensen is a prominent inventor based in København, Denmark. He is known for his significant contributions to the field of nucleic acid chemistry, particularly in the synthesis of Locked Nucleic Acid (LNA) derivatives. His innovative work has implications for various applications in molecular biology and therapeutic development.

Latest Patents

Mads Detlef Sorensen holds a patent for the "Synthesis of locked nucleic acid derivatives." This invention presents a novel strategy for synthesizing various LNA derivatives, including α-oxy-LNA, amino-LNA, α-amino-LNA, thio-LNA, α-thio-LNA, seleno-LNA, and methylene LNA. The method provides scalable, high-yielding reactions utilizing intermediates that can also produce other LNA analogues, such as oxy-LNA. The compounds of the formula X serve as important intermediates that can react with various nucleophiles, leading to a wide variety of LNA analogues.

Career Highlights

Mads Detlef Sorensen is associated with Santaris Pharma A/S, where he continues to advance his research in nucleic acid technologies. His work has been instrumental in developing innovative solutions that enhance the efficacy of nucleic acid-based therapeutics.

Collaborations

Throughout his career, Mads has collaborated with notable colleagues, including Jesper Wengel and Troels Koch. These collaborations have fostered a productive environment for innovation and research in the field of nucleic acids.

Conclusion

Mads Detlef Sorensen's contributions to the synthesis of Locked Nucleic Acid derivatives highlight his role as a key innovator in the field. His work not only advances scientific understanding but also paves the way for future developments in therapeutic applications.